Jeppe Ragnar Andersen

Jeppe-135x135

Jeppe Ragnar Andersen

Investment Director
Global Clinical Research and Investments
Jeppe Ragnar Andersen is CEO of Nordic Bioscience, Denmark. Jeppe is actively doing research into clinical trial methodology with a special focus on implementing risk-based monitoring and cost-benefit optimization. Over the years, Jeppe has been involved on an operational and executive level in numerous clinical studies with more than 15,000 patients within the therapeutic fields of osteoporosis, osteoarthritis and diabetes. Jeppe brings operational expertise of running global multi-center clinical trials in MSK conditions.